| |
| |
|
| Insider
Information: |
Quisel John D |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
122,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,613,926 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
122,381 |
|
|
| Total
Value |
$11,613,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
EVP, Chief Business Of... |
2020-01-02 |
53,316 |
2014-04-22 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-01-10 |
69,065 |
2023-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
Chief Executive Officer |
• • – |
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
66,365 |
69,065 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
Chief Executive Officer |
• • – |
2023-12-29 |
4 |
OE |
$1.01 |
$2,727 |
D/D |
2,700 |
2,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, Chief Business Officer |
• – – |
2020-01-02 |
4 |
AS |
$52.51 |
$306,806 |
D/D |
(5,842) |
53,316 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
EVP, Chief Business Officer |
• – – |
2019-09-10 |
4 |
AS |
$45.23 |
$162,104 |
D/D |
(3,584) |
59,158 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, Chief Business Officer |
• – – |
2019-07-09 |
4 |
OE |
$3.88 |
$42,908 |
D/D |
8,908 |
62,742 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$44.24 |
$161,671 |
D/D |
(3,622) |
53,834 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
57,456 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2019-01-02 |
4 |
AS |
$42.31 |
$254,490 |
D/D |
(5,942) |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
58,598 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-04-03 |
4 |
AS |
$38.33 |
$46,232 |
D/D |
(1,204) |
56,598 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,825 |
57,802 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-01-02 |
4 |
AS |
$42.42 |
$183,806 |
D/D |
(4,333) |
52,977 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2017-09-13 |
4 |
AS |
$38.03 |
$304 |
D/D |
(8) |
57,310 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2017-09-12 |
4 |
AS |
$38.29 |
$196,118 |
D/D |
(5,105) |
57,318 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,900 |
62,423 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2017-01-04 |
4 |
AS |
$26.43 |
$46,513 |
D/D |
(1,700) |
54,523 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2016-09-21 |
4 |
OE |
$3.88 |
$379,789 |
D/D |
25,952 |
102,175 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2016-09-21 |
4 |
AS |
$38.05 |
$1,748,474 |
D/D |
(45,952) |
56,223 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2016-09-12 |
4 |
AS |
$32.14 |
$689,017 |
D/D |
(21,438) |
76,223 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2016-09-12 |
4 |
OE |
$3.88 |
$87,719 |
D/D |
16,438 |
97,661 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
81,223 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-09-14 |
4 |
AS |
$33.07 |
$183,425 |
D/D |
(5,500) |
76,123 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-09-14 |
4 |
OE |
$3.88 |
$21,340 |
D/D |
5,500 |
81,623 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
76,123 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-08-14 |
4 |
OE |
$3.88 |
$30,262 |
D/D |
5,500 |
41,623 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
